Verastem (VSTM) Gets a Buy Rating from Alliance Global Partners

In a report released today, Matthew Cross from Alliance Global Partners maintained a Buy rating on Verastem (VSTM – Research Report), with a price target of $6.00. The company’s shares closed last More »

H.C. Wainwright Thinks Cocrystal Pharma’s Stock is Going to Recover

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Cocrystal Pharma (COCP – Research Report), with a price target of $4.00. The company’s shares closed last More »